Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001127855-05-000833
Filing Date
2005-12-30
Accepted
2005-12-29 18:09:09
Documents
6
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 SINOVAC BIOTECH LTD. 20F/A #4, 12.31.04 sinovac20fa4123104.htm 20-F/A 846274
2 SINOVAC BIOTECH LTD. 20F/A #4, CERTIFICATION 302, CEO sinovacexh31_1.htm EX-31.1 7480
3 SINOVAC BIOTECH LTD. 20F/A #4, CERTIFICATION 302, CFO sinovacexh31_2.htm EX-31.2 7208
4 SINOVAC BIOTECH LTD. 20F/A #4, CERTIFICATION 906, CEO sinovacexh32_1.htm EX-32.1 4354
5 SINOVAC BIOTECH LTD. 20F/A #4, CERTIFICATION 906, CFO sinovacexh32_2.htm EX-32.2 4697
6 SINOVAC BIOTECH LTD. 20F/A #4, DIAGRAM 1 sinovac_diagram.jpg GRAPHIC 59369
  Complete submission text file 0001127855-05-000833.txt   953559
Mailing Address 39 SHANGDI XI ROAD HAIDIAN DISTRICT BEIJING F4 100085
Business Address 39 SHANGDI XI ROAD HAIDIAN DISTRICT BEIJING F4 100085 86-10-82890088
SINOVAC BIOTECH LTD (Filer) CIK: 0001084201 (see all company filings)

EIN.: 000000000 | State of Incorp.: B9 | Fiscal Year End: 0430
Type: 20-F/A | Act: 34 | File No.: 001-32371 | Film No.: 051292422
SIC: 2834 Pharmaceutical Preparations